Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Do You Know Where Your Instruments Are? How Surgical Instrument Marking Can Improve Your Perioperative feat. Bill Camargo and Jennifer Bingaman

Ahead of any surgical procedure or operation is the preparation of surgical instruments. In the latest episode of the podcast “ConCensis,” host Tyler Kern discussed the ins and outs of how Censis utilizes its software to facilitate the use of surgical instruments throughout the full perioperative loop by putting marks on each individual instrument. He…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Censis on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Ahead of any surgical procedure or operation is the preparation of surgical instruments. In the latest episode of the podcast “ConCensis,” host Tyler Kern discussed the ins and outs of how Censis utilizes its software to facilitate the use of surgical instruments throughout the full perioperative loop by putting marks on each individual instrument. He spoke with Bill Camargo, Manager of Marking Services, and Jennifer Bingaman, Director of Business Services, on how Censis gets it right.

According to Camargo, there are three main types of surgical instrument markings commonly used – laser, electrochemical, and mechanical. Laser is the most popular, however, there are instances where one or more may be utilized together. For laser marking a significant amount of space is needed between the lens and instrument of marking, so that’s when electrochemical and mechanical marking come into play.

“With some instrument configurations, it’s very difficult, if not impossible, to mark it with a laser, that’s where electrochemical comes into play,” said Camargo. He went on to note that mechanical markings come through with a solution if the former two aren’t the best options. The downside to mechanical markings is their lack of permanence.

Marking allows the perioperative to be as smooth and clear as possible. It also makes the job of operating room (OR) staff members much smoother, particularly in critical times. Facilities choose to mark instruments to maintain efficient organization and tracking, according to Bingaman.

“There’s usually two main reasons why people choose to mark instruments, the biggest being that when you’re assembling a tray in sterile processing and you’re able to scan each instrument to that set, it helps ensure that you have a complete set to the OR, so that OR staff aren’t spending their time looking for missing instruments,” said Bingaman.

Surgical instrument marking also makes identifying and pinpointing the source of any issue that might arise during a procedure. While each surgical instrument tray is unique, when surgical instruments have markings, it clarifies a particular instrument giving you a deeper level of tracking information.

“If God forbid there’s an infection control issue, then if you have instruments marked and you’re scanning at instrument level, then you know exactly what instruments were used on that patient, rather than just knowing this tray was used on this patient. You actually get down to the instrument level,” said Bingaman.

Censis’s CensiTrac software adds another element that improves surgical instrument marking and tracking. Bingaman compared the tracking method to manufacturing barcodes. Similar to how barcodes identify what products were just scanned in a grocery store for example, entering surgical instrument data into the CensiTrac system will help it know what instrument is being used.

Interested in learning more about Censis Technologies’ surgical asset management platform? Visit Censis.com.

Censis

Part of this channel

Censis

Surgical instrument management software for over 1,300 U.S. hospitals.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512